These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9532908)

  • 1. [Characteristics of histocompatibility antigens distribution in patients with multiple sclerosis].
    Shiralieva RK; Guseĭnova KA
    Klin Med (Mosk); 1998; 76(1):19-20. PubMed ID: 9532908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinico-immunologic parallels in multiple sclerosis].
    Prokof'ev VF; Konenkov VI; Gribacheva IA; Voronova IA; Doronin BM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(2):31-4. PubMed ID: 2728717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
    Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
    Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined influences of Gm and HLA phenotypes upon multiple sclerosis susceptibility and severity.
    Salier JP; Sesboüé R; Martin-Mondière C; Daveau M; Cesaro P; Cavelier B; Coquerel A; Legrand L; Goust JM; Degos JD
    J Clin Invest; 1986 Aug; 78(2):533-8. PubMed ID: 3461005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-antigen frequencies in patients with progressive systemic sclerosis and morphea.
    Kühnl P; Sibrowski W; Kalmar G; Holzmann H; Sollberg S; Böhm BO
    Beitr Infusionsther; 1990; 26():287-9. PubMed ID: 1703854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Histocompatibility antigens in multiple sclerosis patients].
    Khondkarian OA; Tananov AT; Zavalishin IA; Nevskaia OM; Kut'ina RM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(2):7-10. PubMed ID: 7234266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
    Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström AC; Remberger M
    Tissue Antigens; 2008 Dec; 72(6):549-58. PubMed ID: 19000143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunogenetic markers of disseminated sclerosis in western Siberia].
    Prokof'ev VF; Gribacheva IA; Konenkov VI; Doronin BM; Voronova IA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(12):49-52. PubMed ID: 3245376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multiple sclerosis and the histocompatibility system].
    Khondkarian OA; Tananov AT; Zavalishin IA; Nevskaia OM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):167-71. PubMed ID: 6176089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethnic differences in HLA antigens in Chilean donors and recipients: data from the National Renal Transplantation Program.
    Droguett MA; Beltran R; Ardiles R; Raddatz N; Labraña C; Arenas A; Flores J; Alruiz P; Mezzano S; Ardiles L
    Transplant Proc; 2008 Nov; 40(9):3247-50. PubMed ID: 19010245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complement markers Bf and C4 in multiple sclerosis].
    Fauchet R; Madigand M; Gueguen-Duchesne MY; Papin J; Sabouraud O; Genetet B
    Rev Neurol (Paris); 1984; 140(6-7):422-5. PubMed ID: 6611572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunogenetic markers in the course of vibration disease].
    Sideltseva EV; Kolesov VG; Aleksev LP; Sideltsev VV
    Med Tr Prom Ekol; 1993; (11-12):27-30. PubMed ID: 7921836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA status in patients with chronic spontaneous urticaria.
    Bozek A; Krajewska J; Filipowska B; Polanska J; Rachowska R; Grzanka A; Jarzab J
    Int Arch Allergy Immunol; 2010; 153(4):419-23. PubMed ID: 20559009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA antigens in multiple sclerosis in Alsace.
    Rumbach L; Tongio MM; Warter JM; Marescaux C; Grange D; Mayer S; Collard M
    Biomed Pharmacother; 1985; 39(7):385-9. PubMed ID: 3830266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HLA-DRW antigens and multiple sclerosis].
    De Moerloose PH; Jeannet M; Martins-da-Silva B; Werner-Favre C; Rohr J; Gauthier G
    Schweiz Arch Neurol Neurochir Psychiatr; 1978; 123(1):51-61. PubMed ID: 83671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Disseminated sclerosis. Possible correlation between clinical forms and HLA groups (author's transl)].
    Madigand M; Fauchet R; Oger J; Sabouraud O
    Nouv Presse Med; 1981 Jun; 10(28):2349-52. PubMed ID: 7267340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of A, B, C and DR antigens in definite Meniere's disease in a Spanish population.
    López-Escámez JA; López-Nevot A; Cortes R; Ramal L; López-Nevot MA
    Eur Arch Otorhinolaryngol; 2002 Aug; 259(7):347-50. PubMed ID: 12189399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histocompatibility (HLA) antigens and multiple sclerosis in Israelis.
    Brautbar C; Amar A; Cohen I; Kahana E; Cohen T; Bloch D; Grosse-Wilde H; Alter M
    Isr J Med Sci; 1982 May; 18(5):631-4. PubMed ID: 7096048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis.
    Silva AM; Bettencourt A; Pereira C; Santos E; Carvalho C; Mendonça D; Costa PP; Monteiro L; Martins B
    Mult Scler; 2009 Jun; 15(6):771-4. PubMed ID: 19482867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HLA-A, B, C phenotype frequencies in progressive systemic scleroderma].
    Baldauf C; Schaller J; Herrmann K; Haustein UF
    Dermatol Monatsschr; 1989; 175(1):16-9. PubMed ID: 2920860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.